Medical Treatments: Innovation

(asked on 18th December 2014) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, what process is in place to co-ordinate the review of the evaluation of cancer drugs led by Bruce Keogh and the Freeman review into innovative medicines and medical technology.


Answered by
George Freeman Portrait
George Freeman
This question was answered on 5th January 2015

NHS England has advised that representatives from NHS England, the Department of Health, the National Institute for Health and Care Excellence, ten key cancer charities, and the pharmaceutical industry met on 4 December 2014, to discuss the future of cancer drugs commissioning. They have committed to establishing a working group, to meet early in the new year, to develop a robust process to support the sustainable long-term commissioning of cancer drugs.

The external review of the pathways for the development, assessment, and adoption of innovative medicines and medical technology will consider how to speed up access for National Health Service patients to cost-effective new diagnostics, medicines and devices. We are still establishing the processes by which the review will link with other pieces of work in progress and we expect the review will be able to take account of the work NHS England is coordinating on the commissioning of cancer drugs.

Reticulating Splines